Understanding the Preference of a Dipeptidyl Peptidase-4 Inhibitor and its Combination Therapy in Type 2 Diabetes Mellitus among Indian Clinicians

Background: Multiple dipeptidyl peptidase-4 inhibitors (DPP4is) are available in India. The class of DPP4i presents as a heterogeneous group with differences among the molecules. Thus, there is a need to evaluate the choice of DPP4i and its combinations among Indian clinicians. This survey aims to a...

وصف كامل

التفاصيل البيبلوغرافية

المؤلفون الرئيسيون:	K. V. S. Hari Kumar, Shreerang Godbole, Faraz Farishta, Suresh Damodharan, Deodatta Chafekar, Akshay Bafna, Rahul Iyer, Amarnath Sugumaran, Senthilnathan Mohanasundaram
التنسيق:	Artigo
اللغة:	Inglês
منشور في:	Wolters Kluwer Medknow Publications 2024-10-01
سلاسل:	International Journal of Diabetes and Technology
الموضوعات:	dipeptidyl peptidase-4 inhibitors sodium–glucose cotransporter 2 inhibitor type 2 diabetes mellitus
الوصول للمادة أونلاين:	https://journals.lww.com/10.4103/ijdt.ijdt_39_24
الوسوم:	إضافة وسم لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!